Accueil   Diary - News   All news Advanced BioDesign and LIH join forces to explore new therapeutic strategies

Advanced BioDesign and LIH join forces to explore new therapeutic strategies

Advanced BioDesign and Luxembourg Institute of Health (LIH) join forces to explore new therapeutic strategies for overcoming tumor resistance

 

Partnership between Dr Bassam Janji’s TIME research team at LIH and Advanced BioDesign will see parties pool expertise to treat solid tumors


Lyon, France, and Luxembourg, July 1, 2020 – Advanced BioDesign, a French biotechnology company specializing in the development of innovative therapies for resistant forms of cancer, and the Luxembourg Institute of Health (LIH), a public biomedical research institute, announce today a partnership to embark on a collaborative research program. The general objective of this partnership is to combine Advanced BioDesign’s expertise on targeting the specific cellular metabolism of tumors with the recognized experience of Dr Bassam Janji’s TIME (Tumor Immunotherapy and Microenvironment) research group on identiying mechanisms regulating the anti-tumor immune system. More specifically, the LIH research group TIME will be able to investigate the efficacy of Advanced BioDesign’s compounds in particularly severe pathologies where tumor immunosuppression constitutes a survival mechanism for cancer cells.

 

Read the press release